cristina suárez, md, compares the control arm of checkmate 9er with current 1st line rcc regimens
Published 3 years ago • 68 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:37
dr. amin on rationale for checkmate-214 trial in rcc
-
18:21
transitional cell carcinoma of the kidneys 2022: pearls and pitfalls - part 3
-
6:14
renal tumors case 9
-
1:02
key rcc data: javelin renal 101 & checkmate 214
-
10:24
the typical prognosis of aggressive renal cell cancer
-
23:40
ct kidneys and bladder - five pathologic cases discussed
-
56:59
renal cell carcinoma
-
16:53
transitional cell carcinoma of the kidneys 2022: pearls and pitfalls - part 2
-
0:31
rcc metastasis to adrenal
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
11:52
renal cell carcinoma (kidney cancer) - a tutorial by oster oncology
-
1:00
renal cell carcinoma in horseshoe kidney
-
0:33
clear-cell metastatic renal cell carcinoma to ulna
-
1:02
ctdna testing for mrd – reliable, sensitive, and specific, but challenges remain: 2022 esmo florida
-
5:36
sequencing metastatic renal cell carcinoma treatments
-
1:20
what does a 3% cds risk score mean?
-
0:47
renal medullary carcinoma
-
1:51
cdr3s and renalase-1 correlate with increased melanoma survival | oncotarget
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
1:46
renal cell carcinoma - ct scan - basic radiology